Tag: Industry
-
Counting Stars: Why an Astrocentric Perspective Matters for CNS Drug Discovery
A new invited pharmaceutical industry editorial by Dr Nat Hastings, Cellestial’s CEO, has recently been published in IBI by SENGLOBAL LTD. 𝗪𝗵𝗮𝘁 𝘄𝗲 𝗹𝗲𝗮𝗿𝗻𝘁:✦ CNS drug discovery focusses on a relatively limited number of targets✦ Traditionally, these targets centre on protection or replacement of neurones✦ Conceptual frameworks define drug target selection more than tools✦ Limited…